Zantac & Ranitidine

Hundreds of lawsuits filed by Zantac, ranitidine users diagnosed with cancer

In 2019, the heartburn medications Zantac and ranitidine were recalled and studies showed that they were contaminated with a chemical that could increase the cancer risk of patients who were treated with these drugs. Consumers who used Zantac or ranitidine and were diagnosed with cancer may qualify to file a lawsuit and receive compensation for their injuries. (more…)

By |2020-06-06T16:13:05+00:00June 6th, 2020|Zantac & Ranitidine|Comments Off on Hundreds of lawsuits filed by Zantac, ranitidine users diagnosed with cancer

CVS, Walgreens, Walmart, and other pharmacy chains recall Zantac and ranitidine over cancer concerns

Several nationwide pharmacy chains have pulled Zantac from stores over concerns that the popular heartburn drug and its generic equivalent, ranitidine, could cause cancer. CVS, Target, Walgreens, Walmart, and other pharmacies have voluntarily recalled Zantac and ranitidine following a warning by the Food and Drug Administration (FDA) that these drugs were contaminated with a chemical that could increase the risk of cancer for patients being treated for conditions caused by too much stomach acid. (more…)

By |2019-12-17T22:31:30+00:00December 10th, 2019|Zantac & Ranitidine|Comments Off on CVS, Walgreens, Walmart, and other pharmacy chains recall Zantac and ranitidine over cancer concerns

Sanofi recalls Zantac OTC due to chemical contamination that may cause cancer

Sanofi has announced that it is recalling the popular heartburn drug Zantac OTC. The drugmaker made the announcement following tests that found that Zantac was contaminated with a chemical impurity that can increase the risk of cancer. (more…)

By |2019-12-17T22:33:31+00:00October 25th, 2019|Zantac & Ranitidine|Comments Off on Sanofi recalls Zantac OTC due to chemical contamination that may cause cancer

Zantac and ranitidine contaminated with cancer-causing chemical, FDA says

An investigation by the U.S. Food and Drug Administration has found that the heartburn drug Zantac and some generic versions of the drug are contaminated with a chemical that may cause cancer. Several national pharmacy chains have pulled Zantac and generic ranitidine from their shelves over concerns that patients who use these medications may face an increased cancer risk. (more…)

By |2019-12-17T22:33:47+00:00October 14th, 2019|Zantac & Ranitidine|Comments Off on Zantac and ranitidine contaminated with cancer-causing chemical, FDA says